The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis.
Haberal
M
M
Turkish Transplantation and Burn Foundation Medical Center, Ankara.
Sert
S
S
Gülay
H
H
Arslan
G
G
Bilgin
N
N
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3; D010956:Plasmapheresis; D013256:Steroids / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D013256:Steroids